Skip to main content

Breadcrumb

  1. Home

Sensitive detection of ctDNA in early-stage non-small cell lung cancer patients with a personalized sequencing assay

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Sensitive detection of ctDNA in early-stage non-small cell lung cancer patients with a personalized sequencing assay

Role of circulating tumor DNA (ctDNA) from Liquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation (LIBERTI)

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Role of circulating tumor DNA (ctDNA) from Liquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation (LIBERTI)

Reduction of tumor-infiltrating B cells linked to recurrence of NSCLC tumors

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Reduction of tumor-infiltrating B cells linked to recurrence of NSCLC tumors

Profiling exhausted T cells using Vectra® Polaris™multiplex immunofluorescence assay in HNSCC

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Profiling exhausted T cells using Vectra® Polaris™multiplex immunofluorescence assay in HNSCC

Distinguishing dendritic cell subtypes in the tumor microenvironment using MultiOmyxTM

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Distinguishing dendritic cell subtypes in the tumor microenvironment using MultiOmyxTM

Analytical development of the RaDaRTM assay, a highly sensitive and specific assay for the monitoring of minimal residual disease

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Analytical development of the RaDaRTM assay, a highly sensitive and specific assay for the monitoring of minimal residual disease

A comprehensive genomic profiling approach to interrogate hematologic malignancies

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about A comprehensive genomic profiling approach to interrogate hematologic malignancies

Different genomic mutations signatures are associated to specific PD-L1/TMB states on lung cancer with potential value for patients screening for immunotherapy

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Different genomic mutations signatures are associated to specific PD-L1/TMB states on lung cancer with potential value for patients screening for immunotherapy

STAG2-mutated AML patients: ASXL1 cohesin binding motif status and mutation landscape

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about STAG2-mutated AML patients: ASXL1 cohesin binding motif status and mutation landscape

Variant IGH FISH Patterns in Plasma Cell Myeloma

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Variant IGH FISH Patterns in Plasma Cell Myeloma

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • …
  • Next page Next
  • Last page Last
Subscribe to